As of 2026-09-22, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -13.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 1,686.57 mil USD. INBX's TTM EBITDA according to its financial statements is -125.77 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 16.6x | 16.0x |
| Forward P/E multiples | 17.8x - 19.6x | 18.8x |
| Fair Price | (155.87) - (145.59) | (151.89) |
| Upside | -239.1% - -229.9% | -235.6% |
| Date | EV/EBITDA |
| 2026-09-22 | -13.45 |
| 2026-09-21 | -13.41 |
| 2026-09-18 | -13.10 |
| 2026-09-17 | -12.56 |
| 2026-09-16 | -12.21 |
| 2026-09-15 | -12.66 |
| 2026-09-14 | -13.23 |
| 2026-09-11 | -13.09 |
| 2026-09-10 | -13.34 |
| 2026-09-09 | -13.51 |
| 2026-09-08 | -13.68 |
| 2026-09-04 | -14.47 |
| 2026-09-03 | -14.60 |
| 2026-09-02 | -14.92 |
| 2026-09-01 | -14.88 |
| 2026-08-31 | -15.12 |
| 2026-08-28 | -14.74 |
| 2026-08-27 | -14.80 |
| 2026-08-26 | -14.96 |
| 2026-08-25 | -14.66 |
| 2026-08-24 | -12.58 |
| 2026-08-21 | -12.43 |
| 2026-08-20 | -11.91 |
| 2026-08-19 | -12.18 |
| 2026-08-18 | -11.38 |
| 2026-08-17 | -11.07 |
| 2026-08-14 | -10.65 |
| 2026-08-13 | -11.66 |
| 2026-08-12 | -11.81 |
| 2026-08-11 | -11.12 |
| 2026-08-10 | -11.20 |
| 2026-08-07 | -10.68 |
| 2026-08-06 | -10.35 |
| 2026-08-05 | -10.13 |
| 2026-08-04 | -10.08 |
| 2026-08-03 | -9.99 |
| 2026-07-31 | -9.91 |
| 2026-07-30 | -10.22 |
| 2026-07-29 | -9.59 |
| 2026-07-28 | -9.64 |
| 2026-07-27 | -9.96 |
| 2026-07-24 | -9.85 |
| 2026-07-23 | -10.26 |
| 2026-07-22 | -10.36 |
| 2026-07-21 | -10.56 |
| 2026-07-20 | -10.15 |
| 2026-07-17 | -10.53 |
| 2026-07-16 | -10.73 |
| 2026-07-15 | -10.98 |
| 2026-07-14 | -11.21 |